Maplebear
CART
57.31
-0.53
-0.92%
Maplebear
US · CART
#1429 by market cap
Listed 2023
57.31
-0.53
-0.92%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
A-
Momentum strategy signal
Hold
Analyst consensus
Hold
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
3 8
■ Upgrades■ Downgrades
- 3 upgrades vs 8 downgrades among tracked analyst rating changes.
- Most recent: Wedbush moved from Buy to Hold on 2026-10-30.
Analyst consensus 18 analysts
Hold
Avg price target 63.00 +9.9%
Price target rangecurrent 57.31
Low55.00
Avg63.00
High65.00
Buy 22%
Hold 78%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-02 | Baird | -- | Hold | 65.00 |
| 2026-11-02 | Citi | -- | Buy | 65.00 |
| 2026-10-30 | Cantor Fitzgerald | -- | Hold | 65.00 |
| 2026-10-30 | Bernstein | -- | Hold | 65.00 |
| 2026-10-30 | Wedbush | -- | Hold | 65.00 |
| 2026-10-30 | Citizens JMP | -- | Hold | -- |
| 2026-10-30 | Morgan Stanley | -- | Hold | 65.00 |
| 2026-10-30 | Needham | -- | Hold | -- |
| 2026-10-29 | Raymond James | -- | Hold | -- |
| 2026-10-29 | Baird | -- | Hold | 65.00 |
| 2026-10-29 | Jefferies | -- | Hold | 65.00 |
| 2026-10-29 | Guggenheim | -- | Hold | -- |
| 2026-10-29 | Barclays | -- | Hold | 65.00 |
| 2026-10-26 | Bernstein | -- | Buy | 60.00 |
| 2026-10-26 | Wedbush | -- | Buy | 63.00 |
| 2026-10-26 | Citi | -- | Buy | 58.00 |
| 2026-10-12 | Bernstein | -- | Buy | 60.00 |
| 2026-10-12 | Goldman Sachs | -- | Buy | 65.00 |
| 2026-10-05 | Wells Fargo | -- | Hold | 56.00 |
| 2026-10-04 | Wells Fargo | -- | Hold | 56.00 |
| 2026-09-28 | BTIG | -- | Hold | -- |
| 2026-09-25 | Wells Fargo | -- | Hold | 54.00 |
| 2026-09-22 | Wells Fargo | -- | Hold | 54.00 |
| 2026-09-16 | Wells Fargo | -- | Hold | 54.00 |
| 2026-09-10 | Bernstein | -- | Buy | 60.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-30 | Wedbush | Buy → Hold | 65.00 |
| 2026-10-30 | Cantor Fitzgerald | Buy → Hold | 65.00 |
| 2026-10-30 | Needham | Buy → Hold | -- |
| 2026-10-30 | Bernstein | Buy → Hold | 65.00 |
| 2026-10-29 | Jefferies | Buy → Hold | 65.00 |
| 2026-10-29 | Barclays | Buy → Hold | 65.00 |
| 2026-10-29 | Raymond James | Buy → Hold | -- |
| 2026-10-29 | Baird | Buy → Hold | 65.00 |
| 2026-08-07 | BNP Paribas | Sell → Hold | 56.00 |
| 2026-07-15 | Wedbush | Sell → Buy | 59.00 |
| 2026-03-30 | Jefferies | Hold → Buy | 45.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | After close | ±5.61% | +0.57% (in line) |
| 2026/Q2 | 2026-08-06 | After close | ±9.07% | +11.41% (beat) |
| 2026/Q1 | 2026-05-06 | -- | ±8.45% | -8.18% (in line) |
| 2025/Q4 | 2026-02-12 | After close | ±12.27% | +9.21% (in line) |
| 2025/Q3 | 2025-11-10 | -- | ±11.89% | +1.58% (in line) |
| 2025/Q2 | 2025-08-07 | After close | ±9.67% | +3.69% (in line) |
| 2025/Q1 | 2025-05-01 | After close | ±10.25% | +13.62% (beat) |
| 2024/Q4 | 2025-02-25 | After close | ±12.38% | -12.26% (in line) |
| 2024/Q3 | 2024-11-12 | After close | ±11.82% | -11.01% (in line) |
| 2024/Q2 | 2024-08-06 | After close | ±13.38% | +2.80% (in line) |
| 2024/Q1 | 2024-05-08 | After close | ±11.11% | -3.71% (in line) |
| 2023/Q4 | 2024-02-13 | After close | ±21.45% | -1.87% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:39 · For reference only, not investment advice and not tailored to your situation.
Maplebear discussion 0 comments